{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T19:13:00Z","timestamp":1788462780707,"version":"build-2803163510"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the National High-Level Hospital Clinical Research Funding of China","award":["2022-PUMCH-B-098"],"award-info":[{"award-number":["2022-PUMCH-B-098"]}]},{"name":"the CAMS Innovation Fund for Medical Sciences","award":["2022-I2M-1-023"],"award-info":[{"award-number":["2022-I2M-1-023"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metabolomics"],"DOI":"10.1007\/s11306-026-02497-3","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T17:12:14Z","timestamp":1782925934000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Serum metabolomic signatures integrating sphingosine-1-phosphate and tetrahydrocortisone improve prognostic assessment in non-ischemic cardiomyopathy"],"prefix":"10.1007","volume":"22","author":[{"given":"Fanglu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benchen","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ligang","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4231-828X","authenticated-orcid":false,"given":"Ning-Yi","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4652-9300","authenticated-orcid":false,"given":"Xiaowei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1966-8241","authenticated-orcid":false,"given":"Xue","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"key":"2497_CR1","doi-asserted-by":"publisher","first-page":"373","DOI":"10.4330\/wjc.v12.i8.373","volume":"12","author":"JA Borovac","year":"2020","unstructured":"Borovac, J. A., D\u2019Amario, D., Bozic, J., & Glavas, D. (2020). Sympathetic nervous system activation and heart failure: Current state of evidence and the pathophysiology in the light of novel biomarkers. World Journal of Cardiology, 12, 373\u2013408.","journal-title":"World Journal of Cardiology"},{"key":"2497_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13071693","author":"I Carlino","year":"2025","unstructured":"Carlino, I., Pirrotta, F., Gennari, L., & Palazzuoli, A. (2025). Current Application of Mineralocorticoid Antagonist (MRA) in Heart Failure and CKD: Does Non-Steroidal Drug Add Novel Insights. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines13071693","journal-title":"Biomedicines"},{"key":"2497_CR3","doi-asserted-by":"publisher","first-page":"1071056","DOI":"10.3389\/fped.2022.1071056","volume":"10","author":"Y Chen","year":"2022","unstructured":"Chen, Y., Zhu, L. D., Zhou, L., Guan, A. H., Wang, Z. Y., Xiao, D., Ma, X. P., & Ren, F. (2022). The multivariate cox regression model for complete enteral nutrition after primary anastomosis in neonates with intestinal atresia. Frontiers In Pediatrics, 10, 1071056.","journal-title":"Frontiers In Pediatrics"},{"key":"2497_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28145345","author":"Z Chen","year":"2023","unstructured":"Chen, Z., Lu, D., Qi, B., Wu, Y., Xia, Y., Chen, A., Li, S., Tang, H., Qian, J., & Ge, J. (2023). Quantitative Profiling of Serum Carnitines Facilitates the Etiology Diagnosis and Prognosis Prediction in Heart Failure. Molecules. https:\/\/doi.org\/10.3390\/molecules28145345","journal-title":"Molecules"},{"key":"2497_CR5","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/j.jacc.2015.02.018","volume":"65","author":"ML Cheng","year":"2015","unstructured":"Cheng, M. L., Wang, C. H., Shiao, M. S., Liu, M. H., Huang, Y. Y., Huang, C. Y., Mao, C. T., Lin, J. F., Ho, H. Y., & Yang, N. I. (2015). Metabolic disturbances identified in plasma are associated with outcomes in patients with heart failure: Diagnostic and prognostic value of metabolomics. Journal of the American College of Cardiology, 65, 1509\u20131520.","journal-title":"Journal of the American College of Cardiology"},{"key":"2497_CR6","doi-asserted-by":"publisher","first-page":"e1054","DOI":"10.1161\/CIR.0000000000000490","volume":"135","author":"SL Chow","year":"2017","unstructured":"Chow, S. L., Maisel, A. S., Anand, I., Bozkurt, B., de Boer, R. A., Felker, G. M., Fonarow, G. C., Greenberg, B., Januzzi, J. L., Kiernan, M. S., Liu, P. P., Wang, T. J., Yancy, C. W., & Zile, M. R. (2017). Role of biomarkers for the prevention, assessment, and management of heart failure: A scientific statement from the american heart association. Circulation, 135, e1054\u2013e1091.","journal-title":"Circulation"},{"key":"2497_CR7","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1093\/eurheartj\/ehm342","volume":"29","author":"P Elliott","year":"2008","unstructured":"Elliott, P., Andersson, B., Arbustini, E., Bilinska, Z., Cecchi, F., Charron, P., Dubourg, O., K\u00fchl, U., Maisch, B., McKenna, W. J., Monserrat, L., Pankuweit, S., Rapezzi, C., Seferovic, P., Tavazzi, L., & Keren, A. (2008). Classification of the cardiomyopathies: A position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. European Heart Journal, 29, 270\u2013276.","journal-title":"European Heart Journal"},{"key":"2497_CR8","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1002\/ehf2.13864","volume":"9","author":"J Feng","year":"2022","unstructured":"Feng, J., Tian, P., Liang, L., Chen, Y., Wang, Y., Zhai, M., Huang, Y., Zhou, Q., Zhao, X., Zhao, L., Huang, B., Huang, L., Zhang, Y., & Zhang, J. (2022). Outcome and prognostic value of N-terminal pro-brain natriuretic peptide and high-sensitivity C-reactive protein in mildly dilated cardiomyopathy vs. dilated cardiomyopathy. ESC Heart Failure, 9, 1625\u20131635.","journal-title":"ESC Heart Failure"},{"key":"2497_CR9","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s10741-005-2344-2","volume":"10","author":"JW Funder","year":"2005","unstructured":"Funder, J. W. (2005). Mineralocorticoid receptors: Distribution and activation. Heart Failure Reviews, 10, 15\u201322.","journal-title":"Heart Failure Reviews"},{"key":"2497_CR10","doi-asserted-by":"publisher","first-page":"678530","DOI":"10.3389\/fcvm.2021.678530","volume":"8","author":"F Graziani","year":"2021","unstructured":"Graziani, F., Lillo, R., & Crea, F. (2021). Rationale for the use of pirfenidone in heart failure with preserved ejection fraction. Frontiers in Cardiovascular Medicine, 8, 678530.","journal-title":"Frontiers in Cardiovascular Medicine"},{"key":"2497_CR11","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ijcard.2022.04.026","volume":"359","author":"Z Gregor","year":"2022","unstructured":"Gregor, Z., Kiss, A. R., Grebur, K., Szab\u00f3, L. E., Merkely, B., V\u00e1g\u00f3, H., & Sz\u0171cs, A. (2022). MR-specific characteristics of left ventricular noncompaction and dilated cardiomyopathy. International Journal of Cardiology, 359, 69\u201375.","journal-title":"International Journal of Cardiology"},{"key":"2497_CR12","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1007\/s00059-020-04903-5","volume":"45","author":"A H\u00e4nselmann","year":"2020","unstructured":"H\u00e4nselmann, A., Veltmann, C., Bauersachs, J., & Berliner, D. (2020). Dilated cardiomyopathies and non-compaction cardiomyopathy. Herz, 45, 212\u2013220.","journal-title":"Herz"},{"key":"2497_CR13","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1161\/CIRCULATIONAHA.117.033502","volume":"137","author":"KA Hicks","year":"2018","unstructured":"Hicks, K. A., Mahaffey, K. W., Mehran, R., Nissen, S. E., Wiviott, S. D., Dunn, B., Solomon, S. D., Marler, J. R., Teerlink, J. R., Farb, A., Morrow, D. A., Targum, S. L., Sila, C. A., Hai, M. T. T., Jaff, M. R., Joffe, H. V., Cutlip, D. E., Desai, A. S., Lewis, E. F., \u2026 Temple, R. J. (2018). 2017 Cardiovascular and stroke endpoint definitions for clinical trials. Circulation, 137, 961\u2013972.","journal-title":"Circulation"},{"key":"2497_CR14","first-page":"666","volume":"86","author":"R Jenni","year":"2001","unstructured":"Jenni, R., Oechslin, E., Schneider, J., Attenhofer Jost, C., & Kaufmann, P. A. (2001). Echocardiographic and pathoanatomical characteristics of isolated left ventricular non-compaction: A step towards classification as a distinct cardiomyopathy. Heart (British Cardiac Society), 86, 666\u2013671.","journal-title":"Heart (British Cardiac Society)"},{"key":"2497_CR15","doi-asserted-by":"publisher","first-page":"1154447","DOI":"10.3389\/fcvm.2023.1154447","volume":"10","author":"A Kovilakath","year":"2023","unstructured":"Kovilakath, A., Wohlford, G., & Cowart, L. A. (2023). Circulating sphingolipids in heart failure. Frontiers In Cardiovascular Medicine, 10, 1154447.","journal-title":"Frontiers In Cardiovascular Medicine"},{"key":"2497_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-95553-2","volume":"15","author":"MV Kozhevnikova","year":"2025","unstructured":"Kozhevnikova, M. V., Belenkov, Y. N., Shestakova, K. M., Ageev, A. A., Markin, P. A., Kakotkina, A. V., Korobkova, E. O., Moskaleva, N. E., Kuznetsov, I. V., Khabarova, N. V., Kukharenko, A. V., & Appolonova, S. A. (2025). Metabolomic profiling in heart failure as a new tool for diagnosis and phenotyping. Scientific Reports, 15, Article 11849.","journal-title":"Scientific Reports"},{"key":"2497_CR17","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.jchf.2017.07.009","volume":"5","author":"DE Lanfear","year":"2017","unstructured":"Lanfear, D. E., Gibbs, J. J., Li, J., She, R., Petucci, C., Culver, J. A., Tang, W. H. W., Pinto, Y. M., Williams, L. K., Sabbah, H. N., & Gardell, S. J. (2017). Targeted metabolomic profiling of plasma and survival in heart failure patients. JACC Heart Failure, 5, 823\u2013832.","journal-title":"JACC Heart Failure"},{"key":"2497_CR18","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1038\/s41591-021-01452-0","volume":"27","author":"GA Lewis","year":"2021","unstructured":"Lewis, G. A., Dodd, S., Clayton, D., Bedson, E., Eccleson, H., Schelbert, E. B., Naish, J. H., Jimenez, B. D., Williams, S. G., Cunnington, C., Ahmed, F. Z., Cooper, A., Rajavarma, V., Russell, S., McDonagh, T., Williamson, P. R., & Miller, C. A. (2021). Pirfenidone in heart failure with preserved ejection fraction: A randomized phase 2 trial. Nature Medicine, 27, 1477\u20131482.","journal-title":"Nature Medicine"},{"key":"2497_CR19","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1161\/01.HYP.0000032031.30374.32","volume":"40","author":"JM Li","year":"2002","unstructured":"Li, J. M., Gall, N. P., Grieve, D. J., Chen, M., & Shah, A. M. (2002). Activation of NADPH oxidase during progression of cardiac hypertrophy to failure. Hypertension (Dallas Tex : 1979), 40, 477\u2013484.","journal-title":"Hypertension (Dallas Tex : 1979)"},{"key":"2497_CR20","doi-asserted-by":"publisher","first-page":"153","DOI":"10.31083\/j.rcm2505153","volume":"25","author":"J Li","year":"2024","unstructured":"Li, J., Mi, S., Wang, M., Li, M., Guo, Q., Yang, F., & Ge, J. (2024). Dynamic LVEF Decline and Serum NT-proBNP and Uric Acid Levels before Heart Transplantation are Independent Predictors of Adverse Outcomes in Young Adult Patients with Dilated Cardiomyopathy. Reviews In Cardiovascular Medicine, 25, 153.","journal-title":"Reviews In Cardiovascular Medicine"},{"key":"2497_CR21","doi-asserted-by":"publisher","DOI":"10.1155\/cdr\/2122089","author":"M Li","year":"2025","unstructured":"Li, M., Liu, W., Mi, S., Wang, M., Wang, Y., Guo, Q., Lian, Z., & Ge, J. (2025). Clinical and echocardiographic risk factors of adverse outcomes in young patients with dilated cardiomyopathy. Cardiovascular Therapeutics. https:\/\/doi.org\/10.1155\/cdr\/2122089","journal-title":"Cardiovascular Therapeutics"},{"key":"2497_CR22","doi-asserted-by":"publisher","unstructured":"McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., B\u00f6hm, M., Burri, H., Butler, J., \u010celutkien\u0117, J., Chioncel, O., Cleland, J. G. F., Coats, A. J. S., Crespo-Leiro, M. G., Farmakis, D., Gilard, M., Heymans, S., Hoes, A. W., Jaarsma, T., Jankowska, E. A., Lainscak, M., Lam, C. S. P., Lyon, A. R., McMurray, J. J. V., Mebazaa, A., Mindham, R., Muneretto, C., Piepoli, F., Price, M., Rosano, S., Ruschitzka, G. M. C., F. and, & Skibelund, K. (2022). A. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC. European Journal of Heart Failure. https:\/\/doi.org\/10.1093\/eurheartj\/ehab368","DOI":"10.1093\/eurheartj\/ehab368"},{"key":"2497_CR23","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1161\/01.HYP.0000203772.78696.67","volume":"47","author":"K Nagata","year":"2006","unstructured":"Nagata, K., Obata, K., Xu, J., Ichihara, S., Noda, A., Kimata, H., Kato, T., Izawa, H., Murohara, T., & Yokota, M. (2006). Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and failure in low-aldosterone hypertensive rats. Hypertension (Dallas Tex : 1979), 47, 656\u2013664.","journal-title":"Hypertension (Dallas Tex : 1979)"},{"key":"2497_CR24","doi-asserted-by":"publisher","first-page":"e0182329","DOI":"10.1371\/journal.pone.0182329","volume":"12","author":"SI Ohkura","year":"2017","unstructured":"Ohkura, S. I., Usui, S., Takashima, S. I., Takuwa, N., Yoshioka, K., Okamoto, Y., Inagaki, Y., Sugimoto, N., Kitano, T., Takamura, M., Wada, T., Kaneko, S., & Takuwa, Y. (2017). Augmented sphingosine 1 phosphate receptor-1 signaling in cardiac fibroblasts induces cardiac hypertrophy and fibrosis through angiotensin II and interleukin-6. PloS One, 12, e0182329.","journal-title":"PloS One"},{"key":"2497_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics16010152","author":"B \u00d6zlek","year":"2026","unstructured":"\u00d6zlek, B., Tan\u0131k, V. O., Ta\u015f, A., Barut\u00e7u, S., \u00c7uvalc\u0131o\u011flu, B., Tunca, \u00c7., Akbu\u011fa, K., \u015eahin, Y. B., & Akdo\u011fan, M. (2026). Endothelial Activation and Stress Index (EASIX) Predicts In-Hospital Mortality in Acute Decompensated Heart Failure with Reduced Ejection Fraction. Diagnostics. https:\/\/doi.org\/10.3390\/diagnostics16010152","journal-title":"Diagnostics"},{"key":"2497_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11144135","author":"J Paluszkiewicz","year":"2022","unstructured":"Paluszkiewicz, J., Milting, H., Ka\u0142u\u017cna-Oleksy, M., Pyda, M., Janus, M., K\u00f6rperich, H., & Piran, M. (2022). Left Ventricular Non-Compaction Cardiomyopathy-Still More Questions than Answers. Journal of Clinical Medicine. https:\/\/doi.org\/10.3390\/jcm11144135","journal-title":"Journal of Clinical Medicine"},{"key":"2497_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10010135","author":"L P\u00e9rez-Carrillo","year":"2022","unstructured":"P\u00e9rez-Carrillo, L., Gim\u00e9nez-Escamilla, I., Mart\u00ednez-Dolz, L., S\u00e1nchez-L\u00e1zaro, I. J., Portol\u00e9s, M., Rosell\u00f3-Llet\u00ed, E., & Taraz\u00f3n, E. (2022). Implication of Sphingolipid Metabolism Gene Dysregulation and Cardiac Sphingosine-1-Phosphate Accumulation in Heart Failure. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines10010135","journal-title":"Biomedicines"},{"key":"2497_CR28","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1002\/1873-3468.14973","volume":"598","author":"F Phan","year":"2024","unstructured":"Phan, F., Bourron, O., Foufelle, F., Le Stunff, H., & Hajduch, E. (2024). Sphingosine-1-phosphate signalling in the heart: Exploring emerging perspectives in cardiopathology. FEBS Letters, 598, 2641\u20132655.","journal-title":"FEBS Letters"},{"key":"2497_CR29","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1093\/eurheartj\/ehv727","volume":"37","author":"YM Pinto","year":"2016","unstructured":"Pinto, Y. M., Elliott, P. M., Arbustini, E., Adler, Y., Anastasakis, A., B\u00f6hm, M., Duboc, D., Gimeno, J., de Groote, P., Imazio, M., Heymans, S., Klingel, K., Komajda, M., Limongelli, G., Linhart, A., Mogensen, J., Moon, J., Pieper, P. G., Seferovic, P. M., Schueler, S., Zamorano, J. L., Caforio, A. L. P., & Charron, P. (2016). Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: A position statement of the ESC working group on myocardial and pericardial diseases. European Heart Journal, 37, 1850\u20131858.","journal-title":"European Heart Journal"},{"key":"2497_CR30","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1161\/01.RES.0000080521.15238.E5","volume":"93","author":"W Qin","year":"2003","unstructured":"Qin, W., Rudolph, A. E., Bond, B. R., Rocha, R., Blomme, E. A. G., Goellner, J. J., Funder, J. W., & McMahon, E. G. (2003). Transgenic model of aldosterone-driven cardiac hypertrophy and heart failure. Circulation Research, 93, 69\u201376.","journal-title":"Circulation Research"},{"key":"2497_CR31","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.hrtlng.2025.08.009","volume":"74","author":"A Ta\u015f","year":"2025","unstructured":"Ta\u015f, A., Tunca, \u00c7., Tan\u0131k, V. O., & \u00d6zlek, B. (2025). The Scottish inflammatory prognostic score: A novel biomarker for predicting in-hospital mortality in acute heart failure with reduced ejection fraction. Heart & Lung: The Journal of Critical Care, 74, 291\u2013299.","journal-title":"Heart & Lung: The Journal of Critical Care"},{"key":"2497_CR32","doi-asserted-by":"publisher","first-page":"415","DOI":"10.14744\/cpr.2025.17674","volume":"47","author":"\u00c7 Tunca","year":"2025","unstructured":"Tunca, \u00c7., \u00d6zkan, M. T., Ta\u015f, A., \u0130bi\u015f, A., K\u0131vrak, A., & Tan\u0131k, V. O. (2025). Prognostic value of modified glasgow prognostic score in acute decompensated heart failure with reduced ejection fraction. Journal of Clinical Practice and Research, 47, 415\u2013423.","journal-title":"Journal of Clinical Practice and Research"},{"key":"2497_CR33","doi-asserted-by":"publisher","first-page":"1340708","DOI":"10.3389\/fcvm.2024.1340708","volume":"11","author":"F Vancheri","year":"2024","unstructured":"Vancheri, F., Longo, G., & Henein, M. Y. (2024). Left ventricular ejection fraction: Clinical, pathophysiological, and technical limitations. Frontiers in Cardiovascular Medicine, 11, 1340708.","journal-title":"Frontiers in Cardiovascular Medicine"},{"key":"2497_CR34","doi-asserted-by":"publisher","first-page":"816404","DOI":"10.3389\/fcvm.2022.816404","volume":"9","author":"W Wang","year":"2022","unstructured":"Wang, W., Chen, W., Lin, X., & Fang, L. (2022). Influence of Right Ventricular Dysfunction on Outcomes of Left Ventricular Non-compaction Cardiomyopathy. Frontiers in Cardiovascular Medicine, 9, 816404.","journal-title":"Frontiers in Cardiovascular Medicine"},{"key":"2497_CR35","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1007\/s11886-023-01944-0","volume":"25","author":"Y Wang","year":"2023","unstructured":"Wang, Y., Jia, H., & Song, J. (2023). Accurate Classification of Non-ischemic Cardiomyopathy. Current Cardiology Reports, 25, 1299\u20131317.","journal-title":"Current Cardiology Reports"},{"key":"2497_CR36","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/S0140-6736(16)31713-5","volume":"390","author":"RG Weintraub","year":"2017","unstructured":"Weintraub, R. G., Semsarian, C., & Macdonald, P. (2017). Dilated cardiomyopathy. Lancet (London England), 390, 400\u2013414.","journal-title":"Lancet (London England)"},{"key":"2497_CR37","first-page":"403","volume":"93","author":"AH Wu","year":"2007","unstructured":"Wu, A. H. (2007). Management of patients with non-ischaemic cardiomyopathy. Heart (British Cardiac Society), 93, 403\u2013408.","journal-title":"Heart (British Cardiac Society)"},{"key":"2497_CR38","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s12944-020-01262-2","volume":"19","author":"Y Xue","year":"2020","unstructured":"Xue, Y., Jiang, W., Ma, Q., Wang, X., Jia, P., Li, Q., Chen, S., Song, B., Wang, Y., Zhang, J., Liu, J., Yang, G., Lin, Y., Liu, J., Wei, L., Dong, C., Li, H., Xie, Z., Bai, L., & Ma, A. (2020). U-shaped association between plasma sphingosine-1-phosphate levels and mortality in patients with chronic systolic heart failure: A prospective cohort study. Lipids in Health and Disease, 19, 125.","journal-title":"Lipids in Health and Disease"},{"key":"2497_CR39","doi-asserted-by":"publisher","first-page":"5477","DOI":"10.2147\/JIR.S515757","volume":"18","author":"M Zhao","year":"2025","unstructured":"Zhao, M., Bian, R., Xu, X., Zhang, J., Zhang, L., & Zheng, Y. (2025). Sphingolipid Metabolism and Signalling Pathways in Heart Failure: From Molecular Mechanism to Therapeutic Potential. Journal of Inflammation Research, 18, 5477\u20135498.","journal-title":"Journal of Inflammation Research"},{"issue":"1","key":"2497_CR40","doi-asserted-by":"publisher","first-page":"5386","DOI":"10.1038\/s41598-024-55996-5","volume":"14","author":"R Zhou","year":"2024","unstructured":"Zhou, R., Xia, Y. Y., Li, Z., Wu, L. D., Shi, Y., Ling, Z. Y., & Zhang, J. X. (2024). HFpEF as systemic disease, insight from a diagnostic prediction model reminiscent of systemic inflammation and organ interaction in HFpEF patients. Scientific Reports, 14, 5386.","journal-title":"Scientific Reports"},{"key":"2497_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/cimb47070481","author":"M Zhou","year":"2025","unstructured":"Zhou, M., Song, X., Yu, Q., Dai, B., Zhou, W., Zan, X., & Deng, W. (2025). Metabolomics and Transcriptome Analysis of Rapeseed Under Salt Stress at Germination Stage. Current Issues in Molecular Biology. https:\/\/doi.org\/10.3390\/cimb47070481","journal-title":"Current Issues in Molecular Biology"}],"container-title":["Metabolomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11306-026-02497-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11306-026-02497-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11306-026-02497-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T18:20:56Z","timestamp":1788459656000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11306-026-02497-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":41,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["2497"],"URL":"https:\/\/doi.org\/10.1007\/s11306-026-02497-3","relation":{},"ISSN":["1573-3890"],"issn-type":[{"value":"1573-3890","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"assertion":[{"value":"5 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Ethics Committee of Peking Union Medical College Hospital (Approval No. I-25PJ0792) and was conducted in accordance with the principles of the Declaration of Helsinki.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all participants prior to enrollment.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"108"}}